PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Onefish Twofish Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Themis Analytics Wins Queen’s Award for Enterprise in International Trade 2010 - Themis Analytics, a leading provider of business intelligence and marketing information services and solutions for the global pharmaceutical industry, is announced today as a winner of the coveted Queen’s Award for Enterprise in International Trade
Themis Analytics Wins Queen’s Award for Enterprise in International Trade 2010

 

NewswireToday - /newswire/ - Pangbourne, Berkshire, United Kingdom, 2010/04/21 - Themis Analytics, a leading provider of business intelligence and marketing information services and solutions for the global pharmaceutical industry, is announced today as a winner of the coveted Queen’s Award for Enterprise in International Trade.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Queen’s Awards for Enterprise are the UK’s most prestigious awards for business performance. They recognise and reward outstanding achievement by UK companies. For Wiltshire based company, Themis Analytics, this award has been given most notably for the increase in exports that have tripled over the last six years, and also in recognition of its significant and consistent growth. This outstanding achievement is testament to a highly effective marketing strategy which has grown out of the ability to establish and maintain long term, in-depth relationships with the head offices and regional offices of global clients. Themis Analytics’ client base includes some of the world’s leading corporations, many of whom have been partnering with Themis Analytics for many years. In fact, 80% of the company’s turnover last year was due to repeat business.

Themis Analytics was founded 17 years ago by David Holmes, from his home in a Wiltshire farmhouse. David explains, ‘After a career in Pharmaceutical Marketing Research, I realised there was a real need to make better use of the data we were creating as an industry. ‘Themis’ was a Greek goddess tasked with organising the affairs of men and my original idea was just this: that it should be a lot easier to organise and integrate data into information with a graphical view of trends to aid in decision making. We began our journey with just one major pharmaceutical client, and now, 17 years later, they still form part of our ever increasing client base of blue-chip companies. The original vision has been realised and our teams in the UK and the USA are supporting customers around the world. We are proud and delighted to have been recognised by the Queens Award’.

Themis Analytics has a keen focus on monitoring trends within the industry and developing its solutions to fulfil client needs. CEO Greg Schlimm comments, ‘The pharmaceutical industry today faces more challenges than ever before, and the complexity is increasing as drug launches become more niche and specialised. Over the years we have consistently pushed ourselves to utilise leading edge technologies to create more sophisticated market offerings. In order to support this monumental change in the industry, we are launching Themis Version 7 this summer with a whole set of new analytic capabilities for more individualised needs. Our market offerings are now even broader and we have seen our customer base grow significantly, however, our core value proposition to our clients remains firmly based on David’s original vision. This award recognises our dedication and commitment and has inspired us to continue to aim for excellence.’

About Themis Analytics

Themis Analytics (themisanalytics.com) is a leading provider of business intelligence solutions specifically designed to meet the business needs of the pharmaceutical industry. Founded in 1993, the company has 17 years of experience in providing leading edge market intelligence products and services to thousands of users across 70 countries, representing many of the world’s leading corporations. Themis Analytics’ mission and goal is to enable any decision maker, anywhere in the world, at any time, to access the best data source available. Thus enabling them to understand the dynamics of the market and to make decisions with confidence.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Onefish Twofish Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Themis Analytics Wins Queen’s Award for Enterprise in International Trade 2010

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Liz Hayward - OnefishTwofish.co.uk 
+44 118 321 7457 liz[.]onefishtwofish.co.uk
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Onefish Twofish Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Onefish Twofish Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)